Winston Medical Supply Co., Ltd. (TPEX:6817)

Taiwan · Delayed Price · Currency is TWD

70.00

0.00 (0.00%)

Apr 29, 2026, 1:38 PM CST

-29.86% (1Y)

Market Cap	1.28B
Revenue (ttm)	700.07M
Net Income (ttm)	117.29M
Shares Out	18.42M
EPS (ttm)	6.35
PE Ratio	10.94
Forward PE	n/a
Dividend	5.00 (7.14%)
Ex-Dividend Date	Jun 13, 2025

Volume	4,041
Average Volume	39,532
Open	70.40
Previous Close	70.00
Day's Range	70.00 - 70.40
52-Week Range	64.60 - 117.50
Beta	0.25
RSI	44.23
Earnings Date	Aug 7, 2026

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, che... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1974

Employees 180

Stock Exchange Taipei Exchange

Ticker Symbol 6817

Full Company Profile

Financial Performance

In 2025, Winston Medical Supply's revenue was 700.07 million, an increase of 0.72% compared to the previous year's 695.08 million. Earnings were 117.29 million, a decrease of -10.87%.

Financial Statements

News

There is no news available yet.